Cargando…
The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure
OBJECTIVES: To find the imaging mortality predictors in patients with previous myocardial infarction (MI), symptomatic heart failure (HF), and reduced left ventricle (LV) ejection fraction (EF). METHODS: for the study 39 patients were selected prospectively with prior MI, symptomatic HF, and LVEF ≤4...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466976/ https://www.ncbi.nlm.nih.gov/pubmed/35503304 http://dx.doi.org/10.1177/02676591221100739 |
_version_ | 1785099011558998016 |
---|---|
author | Kazakauskaite, Egle Vajauskas, Donatas Bardauskiene, Lina Ordiene, Rasa Zabiela, Vytautas Zaliaduonyte, Diana Gustiene, Olivija Lapinskas, Tomas Jurkevicius, Renaldas |
author_facet | Kazakauskaite, Egle Vajauskas, Donatas Bardauskiene, Lina Ordiene, Rasa Zabiela, Vytautas Zaliaduonyte, Diana Gustiene, Olivija Lapinskas, Tomas Jurkevicius, Renaldas |
author_sort | Kazakauskaite, Egle |
collection | PubMed |
description | OBJECTIVES: To find the imaging mortality predictors in patients with previous myocardial infarction (MI), symptomatic heart failure (HF), and reduced left ventricle (LV) ejection fraction (EF). METHODS: for the study 39 patients were selected prospectively with prior MI, symptomatic HF, and LVEF ≤40%. All patients underwent transthoracic echocardiography (TTE), single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI), 18F-FDG positron emission tomography (FDG PET). 31 patients underwent cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE). Patients were divided into two groups: 1 group – cardiac death; 2 group – no cardiac death. Myocardial scars were assessed on a 5-point-scale. Follow-up data was obtained. RESULTS: Imaging features disclosed significant difference (p < 0.05) of defect score (CMR and SPECT-PET), LV end-diastolic diameter (EDD) (TTE), LVEDD index (CMR), LV global longitudinal strain (CMR) and LV global circumferential strain (CMR) between the groups. Predictors of cardiac death were: LVEDD index (TTE) and LV global longitudinal strain. The cut-off values to predict cardiac death were: defect score (CMR) 25 (AUC, 79.5%; OR 1.8, 95% CI 1.2–2.7), SPECT-PET defect score 22 (AUC, 73.9%; OR 0.5, 95% CI 0.3–0.7), LVEDD (TTE) 58 mm (AUC, 88.4%; OR 23.6, 95% CI 2.6–217.7), LVEDDi 30 mm/m(2) (TTE) (AUC, 73.6%; OR 22.0, 95% CI 1.9–251.5), LVEDDi 33.6 mm/m(2) (CMR) (AUC, 73.6%; OR 22.0, 95% CI 1.9–251.5), LV global longitudinal strain −13.4 (AUC, 87.8%; OR 2.1, 95% CI 1.2–3.7) and LV global circumferential strain −16.3 (AUC, 76.1%; OR 1.9, 95% CI 1.2–3.0). CONCLUSIONS: Imaging features, such as defect score (CMR) >25, SPECT-PET defect score >22, LVEDD (TTE) >58 mm, LVEDDi (TTE) >30 mm/m(2), LVEDDi (CMR) >33.6 mm/m(2), LV global longitudinal strain −13.4 and LV global circumferential strain −16.3, may increase sensitivity and specificity of FDG PET and LGE CMR predicting of late mortality. |
format | Online Article Text |
id | pubmed-10466976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104669762023-08-31 The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure Kazakauskaite, Egle Vajauskas, Donatas Bardauskiene, Lina Ordiene, Rasa Zabiela, Vytautas Zaliaduonyte, Diana Gustiene, Olivija Lapinskas, Tomas Jurkevicius, Renaldas Perfusion Original Papers OBJECTIVES: To find the imaging mortality predictors in patients with previous myocardial infarction (MI), symptomatic heart failure (HF), and reduced left ventricle (LV) ejection fraction (EF). METHODS: for the study 39 patients were selected prospectively with prior MI, symptomatic HF, and LVEF ≤40%. All patients underwent transthoracic echocardiography (TTE), single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI), 18F-FDG positron emission tomography (FDG PET). 31 patients underwent cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE). Patients were divided into two groups: 1 group – cardiac death; 2 group – no cardiac death. Myocardial scars were assessed on a 5-point-scale. Follow-up data was obtained. RESULTS: Imaging features disclosed significant difference (p < 0.05) of defect score (CMR and SPECT-PET), LV end-diastolic diameter (EDD) (TTE), LVEDD index (CMR), LV global longitudinal strain (CMR) and LV global circumferential strain (CMR) between the groups. Predictors of cardiac death were: LVEDD index (TTE) and LV global longitudinal strain. The cut-off values to predict cardiac death were: defect score (CMR) 25 (AUC, 79.5%; OR 1.8, 95% CI 1.2–2.7), SPECT-PET defect score 22 (AUC, 73.9%; OR 0.5, 95% CI 0.3–0.7), LVEDD (TTE) 58 mm (AUC, 88.4%; OR 23.6, 95% CI 2.6–217.7), LVEDDi 30 mm/m(2) (TTE) (AUC, 73.6%; OR 22.0, 95% CI 1.9–251.5), LVEDDi 33.6 mm/m(2) (CMR) (AUC, 73.6%; OR 22.0, 95% CI 1.9–251.5), LV global longitudinal strain −13.4 (AUC, 87.8%; OR 2.1, 95% CI 1.2–3.7) and LV global circumferential strain −16.3 (AUC, 76.1%; OR 1.9, 95% CI 1.2–3.0). CONCLUSIONS: Imaging features, such as defect score (CMR) >25, SPECT-PET defect score >22, LVEDD (TTE) >58 mm, LVEDDi (TTE) >30 mm/m(2), LVEDDi (CMR) >33.6 mm/m(2), LV global longitudinal strain −13.4 and LV global circumferential strain −16.3, may increase sensitivity and specificity of FDG PET and LGE CMR predicting of late mortality. SAGE Publications 2022-05-03 2023-09 /pmc/articles/PMC10466976/ /pubmed/35503304 http://dx.doi.org/10.1177/02676591221100739 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Papers Kazakauskaite, Egle Vajauskas, Donatas Bardauskiene, Lina Ordiene, Rasa Zabiela, Vytautas Zaliaduonyte, Diana Gustiene, Olivija Lapinskas, Tomas Jurkevicius, Renaldas The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title | The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title_full | The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title_fullStr | The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title_full_unstemmed | The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title_short | The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
title_sort | incremental value of myocardial viability, evaluated by 18f-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466976/ https://www.ncbi.nlm.nih.gov/pubmed/35503304 http://dx.doi.org/10.1177/02676591221100739 |
work_keys_str_mv | AT kazakauskaiteegle theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT vajauskasdonatas theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT bardauskienelina theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT ordienerasa theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT zabielavytautas theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT zaliaduonytediana theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT gustieneolivija theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT lapinskastomas theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT jurkeviciusrenaldas theincrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT kazakauskaiteegle incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT vajauskasdonatas incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT bardauskienelina incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT ordienerasa incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT zabielavytautas incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT zaliaduonytediana incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT gustieneolivija incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT lapinskastomas incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure AT jurkeviciusrenaldas incrementalvalueofmyocardialviabilityevaluatedby18ffluorodeoxyglucosepositronemissiontomographyandcardiovascularmagneticresonanceformortalitypredictioninpatientswithpreviousmyocardialinfarctionandsymptomaticheartfailure |